SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ciphergen Biosystems(CIPH):
An SI Board Since September 2000
Posts SubjectMarks Bans
510 15 0
Emcee:  mact Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
510>>Vermillion Presents Critical Data From Its OVA1 Clinical Trial Tuesday Ftuck-2/10/2009
509East Virginia Medical School, a long time SELDI user, now seems to be heading fotuck-11/30/2007
508>>Vermillion Reports Third Quarter 2007 Financial Results and Business Protuck-11/12/2007
507[Analytical Validation of Serum Proteomic Profiling for Diagnosis of Prostate Catuck-11/12/2007
506[A method for improving SELDI-TOF mass spectrometry data quality] >>Protetuck-9/8/2007
505>>Vermillion, Inc. Announces Receipt of Notice of Noncompliance From Nasdatuck-9/7/2007
504[Intersession Reproducibility of Mass Spectrometry Profiles and its Effect on Actuck-9/5/2007
503[SELDI versus FibroTest for the diagnosis of advanced fibrosis in patients with tuck-9/5/2007
501Now MAS is suing for breach due to the assignment of rights to Bio-Rad: >>tuck-7/17/2007
500>>Health Discovery Corporation Settles Patent Infringement Suit against Cituck-7/6/2007
499OT: I know you like this sort of stuff..... nice broad-band teaser..... &lscaram(o)uche-6/22/2007
498Thoughts as of today? :-)Chartgod-6/22/2007
497[Prediction of chronic hepatitis B, liver cirrhosis and hepatocellular carcinomatuck-5/25/2007
496>>Ciphergen Reports First Quarter 2007 Financial Results and Business Progtuck-5/16/2007
495[Influence of blood sampling on protein profiling and pattern analysis using MALtuck-5/7/2007
494And a "going concern" qualification. Maybe the reproducibility stuff tuck-4/9/2007
493>>Effects of protein stabilizers and storage time on the mass spectrometrytuck-4/9/2007
492>>Reproducibility of proteomic profiles over time in postmenopausal women tuck-4/9/2007
491[SELDI-TOF MS versus prostate specific antigen analysis of prospective plasma satuck-4/7/2007
490[In-Source Decay Causes Artifacts in SELDI-TOF MS Spectra] >>J Proteome Rtuck-3/24/2007
489>>Ciphergen Presents Data Validating Ovarian Cancer Triage Test at Societytuck-3/5/2007
488[Prediction of Diabetic Nephropathy Using Urine Proteomic Profiling 10 Years Prituck-3/1/2007
487[Validation of SELDI-TOF MS serum protein profiles for renal cell carcinoma in ntuck-2/26/2007
486[A Novel ATR-FTIR Approach for Characterisation and Identification of Ex Situ Imtuck-2/24/2007
485First, at the bottom of my last post I mis-typed: I meant ASR or Analyte Speciftuck-2/23/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News